| Nov 7 |
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
|
| Nov 7 |
Becton, Dickinson reports Q3 results, raises FY guidance
|
| Nov 7 |
Becton, Dickinson raises dividend by 9.5% to $1.04
|
| Nov 7 |
BD Board Increases Dividend for 53rd Consecutive Year
|
| Nov 6 |
Becton, Dickinson Q4 2024 Earnings Preview
|
| Nov 4 |
Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings?
|
| Nov 4 |
Insights Into Becton Dickinson (BDX) Q4: Wall Street Projections for Key Metrics
|
| Nov 3 |
Becton, Dickinson and Company (BDX): Expanding Innovations in Medical Technology
|
| Nov 3 |
Wall Street Week Ahead
|
| Nov 1 |
BDX Stock Declines Despite Launching BD IO Vascular Access System
|
